Company profile: NanoString
1.1 - Company Overview
Company description
- Provider of life science tools for basic research, translational medicine, and in vitro diagnostics, offering the CosMx spatial single-cell imaging platform for cell atlasing and biomarker discovery; nCounter data analysis via nSolver and ROSALIND; the nCounter Low RNA Input Kit; a Data Analysis Service; and nCounter panels and assays for gene expression across oncology, neuroscience, and cardiovascular research.
Products and services
- NCounter Panels & Assays: Supplies application-specific gene expression assemblies, offering a range of panels and assays for gene expression analysis in various research areas, including oncology, neuroscience, and cardiovascular diseases
- CosMx Spatial Molecular Imager: Builds single-cell–resolution spatial imaging platforms enabling cell atlasing, analysis of cellular interactions, and biomarker discovery
- ROSALIND: Delivers cloud-based nCounter data analysis systems supporting normalization, QC, pathway analysis, and more, designed for intuitive analysis of nCounter datasets
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to NanoString
Ingenuity
HQ: United States
Website
- Description: Provider of a software platform and information services that enable enterprise customers to give life science researchers access to information via internal portals, search engines, other software, and workflow sources, allowing them to search, explore, visualize, interpret, and analyze complex biological systems.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Ingenuity company profile →
Aura Biosciences
HQ: United States
Website
- Description: Provider of virus-like drug conjugates (VDCs) using virus-like particles to target solid tumors by delivering cytotoxic drugs or nucleic acids. Develops Belzupacap Sarotalocan (Bel-sar) for first-line treatment of early-stage choroidal melanoma and other ocular oncology indications, with potential in choroidal metastasis, aiming to preserve vision and prevent metastatic disease.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Aura Biosciences company profile →
Tango Therapeutics
HQ: United States
Website
- Description: Provider of next-generation cancer therapies leveraging synthetic lethality, including TNG908 and TNG462, PRMT5 inhibitors for MTAP-deleted cancers; TNG260, a CoREST inhibitor aimed at reversing immune evasion in STK11-mutant cancers; and TNG348, a USP1 inhibitor for BRCA1/2-mutant and other HRD+ cancers, all in Phase 1/2 trials. Also provides a CRISPR-based functional genomics platform to identify synthetic lethal targets.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Tango Therapeutics company profile →
Genesis Genetics
HQ: United States
Website
- Description: Provider of preimplantation genetic diagnosis (PGD) and preimplantation genetic screening (PGS), delivering expert laboratory services to respected IVF centers across the country and worldwide for pre-implantation testing of embryos for inherited genetic abnormalities.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Genesis Genetics company profile →
IC Biotec
HQ: United States
Website
- Description: Provider of cloning and associated services to advance reproduction in mammalian species for domestic and international clients across academia and industry, supported by state-of-the-art facilities and a highly skilled scientific team.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full IC Biotec company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for NanoString
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to NanoString
2.2 - Growth funds investing in similar companies to NanoString
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for NanoString
4.2 - Public trading comparable groups for NanoString
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →